Summary
54 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 9.8 USD is left as net profit.
- It holds more cash than debt: $72.9M against $46.2M.
- The share price is below the Bulios Fair Price.
What to watch
- Revenue fell by 9.7% a year over the last 3 years.
- It reports a profit, yet spends more cash than it brings in.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 13.7 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 4.9% a year over 5 years. Over the last 3 years it fell by 9.7% a year.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 56 USD
- Sales and administration 28 USD
- Taxes and other 6.2 USD
- Net profit 9.8 USD
Net profit, industry median (Agricultural Farm Products) 3.9 USD
Out of every 100 USD of revenue, 9.8 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesOver the last 12 months it spent more cash than it brought in. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 7
- Hold 2
- Sell 0
Today's price within the analysts' price targets
The average target of $6.15 is 142% above today's price. 78% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Cannabis Canada Segment 79%
- Produce Business 13%
- Cannabis United States Segment 7.0%
- Energy Business 0.8%
By region
The company reports no revenue by region.
Cannabis Canada Segment brings in 79% of revenue. Energy Business grew fastest, by 37% a year.
Segments in detail